EGFR and colorectal cancer: In the current treatment of colorectal cancer, the evaluation of EGFR and RAS expression from colorectal cancer resected specimens and biopsy specimens selects anticancer drugs and molecular targeted drugs that can be expected to have therapeutic effects [1].